Volatile Oil Containing Plants as Phytopharmaceuticals to Treat Psoriasis: A Review

• Published in: Current pharmaceutical biotechnology Vol. 25; no. 3; p. 313
• Main Authors: Vyas, Priyanka J, Wagh, Shivani S, Kalaskar, Mohan G, Patil, Kalpesh R, Sharma, Ajay K, Kazmi, Imran, Al-Abbasi, Fahad A, Alzarea, Sami I, Afzal, Obaid, Altamimi, Abdulmalik S A, Gupta, Gaurav, Patil, Chandragouda R
• Format: Journal Article
• Language: English
• Published: Netherlands 01.01.2024
• Subjects: pathogenesis; volatile oil; Psoriasis; monoterpenes; phenylpropanoids; sesquiterpenes
• ISSN: 1873-4316
• DOI: 10.2174/1389201024666230607140404

Psoriasis is a chronic skin condition caused by an autoimmune response that accelerates the life cycle of skin cells, resulting in the characteristic symptoms of scaling, inflammation, and itching. Palliative treatment options for psoriasis often prioritize the use of volatile oils. These oils contain monoterpenes, sesquiterpenes, and phenylpropanoids that are intricately linked to the molecular cascades involved in the pathogenesis and symptoms of psoriasis. To evaluate the antipsoriatic efficacy of volatile oils and their components, we conducted a systematic review of scientific studies. Our literature search encompassed various online databases, including PubMed, BIREME, SCIELO, Open Grey, Scopus, and ScienceDirect. The selected studies included experimental assessments as well as clinical studies that examined the potential of volatile oils and their extracts as antipsoriatic agents. We excluded conference proceedings, case reports, editorials, and abstracts. Ultimately, we identified and evaluated a total of 12 studies for inclusion in our analysis. The data collected, compiled, and analyzed strongly support the interaction between volatile oils and their constituents with the key molecular pathways involved in the pathogenesis of psoriasis and the development of its symptoms. Volatile oils play a significant role in the palliative treatment of psoriasis, while their chemical constituents have the potential to reduce the symptoms and recurrence of this condition. The current review highlights that the constituents found in volatile oils offer distinct chemical frameworks that can be regarded as promising starting points for the exploration and development of innovative antipsoriatic agents.